首頁(yè)
瀏覽量: 146
- 產(chǎn)品名稱： Research Grade Risankizumab ( 利散吉珠單抗 )
- 產(chǎn)品貨號(hào)： CSD00400
- 貨期： 現(xiàn)貨
- 價(jià)格與訂購(gòu)： 600
- 數(shù)量：
庫(kù)存： 100
- 規(guī)格： 100μg 1mg
- 產(chǎn)品信息
- 如何訂購(gòu)
貨號(hào)（Catalog No.）
CSD00400
通用名INN
Risankizumab
純度(Purity)
>95%
濃度( Concentration)
1mg/ml
Formulation
PBS buffer PH7.5
Source
CHO cells
內(nèi)毒素(Endotoxin level)
Please contact with the lab for this information.
產(chǎn)品描述(Description)
Risankizumab is a fully humanized IgG1 monoclonal antibody (mAb) that is selective for interleukin 23 (IL-23). On April 23, 2019 it was approved by the FDA (as SKYRIZI) for the treatment of moderate-to-severe plaque psoriasis in adults who are clinically considered eligible for systemic therapy or phototherapy for psoriasis.Label This drug has been commercialized through collaboration between the German pharmaceutical company, Boehringer Ingelheim, and Abbvie.
別名(Alternative names)
BI 655066,risankizumab-rzaa
靶點(diǎn);物種(Specificity target name;species)
IL23A[Homo sapiens]
種類(Species)
Humanized
受體鑒定(Receptor identification)
IgG1-kappa
CAS
1612838-76-2
存儲(chǔ)條件(Storage)
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Store at +4°C short term (1-2 weeks).
Store at -20 °C 12 months.
Store at -80°C long term.
Note
For research use only .
地 址：
產(chǎn)品銷售：
E - mail ：
郵 編：
Amily
